Wilmington Savings Fund Society FSB cut its holdings in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 0.4% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 639,885 shares of the company's stock after selling 2,852 shares during the period. Procter & Gamble comprises about 1.8% of Wilmington Savings Fund Society FSB's portfolio, making the stock its 7th biggest position. Wilmington Savings Fund Society FSB's holdings in Procter & Gamble were worth $101,946,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently bought and sold shares of the company. Nova Wealth Management Inc. purchased a new stake in shares of Procter & Gamble during the first quarter worth approximately $26,000. Signature Resources Capital Management LLC increased its stake in shares of Procter & Gamble by 67.9% during the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock worth $28,000 after buying an additional 72 shares during the period. Quarry LP purchased a new stake in shares of Procter & Gamble during the first quarter worth approximately $33,000. Mizuho Securities Co. Ltd. increased its stake in shares of Procter & Gamble by 566.7% during the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock worth $34,000 after buying an additional 170 shares during the period. Finally, RMG Wealth Management LLC purchased a new stake in shares of Procter & Gamble during the second quarter worth approximately $37,000. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Price Performance
PG stock opened at $147.54 on Tuesday. The company has a market capitalization of $345.32 billion, a P/E ratio of 22.66, a PEG ratio of 3.97 and a beta of 0.36. Procter & Gamble Company has a twelve month low of $146.96 and a twelve month high of $180.43. The business has a 50 day simple moving average of $155.18 and a 200-day simple moving average of $159.27. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to the consensus estimate of $20.79 billion. Procter & Gamble had a return on equity of 32.69% and a net margin of 18.95%.The company's revenue was up 1.7% compared to the same quarter last year. During the same period in the prior year, the company earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, equities analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.
Insiders Place Their Bets
In other news, CEO Jennifer L. Davis sold 3,227 shares of the stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $491,246.21. Following the completion of the sale, the chief executive officer directly owned 61,764 shares of the company's stock, valued at approximately $9,402,333.72. This represents a 4.97% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Shailesh Jejurikar sold 3,986 shares of the stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total value of $606,788.78. Following the sale, the chief operating officer directly owned 46,899 shares of the company's stock, valued at approximately $7,139,434.77. This represents a 7.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 149,763 shares of company stock valued at $23,421,279. 0.20% of the stock is owned by insiders.
Analysts Set New Price Targets
A number of research firms recently weighed in on PG. UBS Group cut their target price on shares of Procter & Gamble from $180.00 to $176.00 and set a "buy" rating on the stock in a research note on Wednesday, October 8th. Weiss Ratings restated a "hold (c+)" rating on shares of Procter & Gamble in a research note on Wednesday, October 8th. Evercore ISI reiterated an "in-line" rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. JPMorgan Chase & Co. dropped their price target on shares of Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating on the stock in a research note on Friday. Finally, Wells Fargo & Company dropped their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating on the stock in a research note on Thursday, September 25th. Eleven research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble has a consensus rating of "Moderate Buy" and a consensus target price of $172.21.
View Our Latest Analysis on PG
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.